Increased MLKL mRNA level in the PBMCs is correlated with autoantibody production, renal involvement, and SLE disease activity

Abstract Background Necroptosis is a form of regulated necrosis that is involved in various autoimmune diseases. Mixed lineage kinase domain-like pseudokinase (MLKL) has been identified as a key executor of necroptosis; however, the significance of MLKL in peripheral blood mononuclear cells (PBMCs)...

Full description

Bibliographic Details
Main Authors: Mingjiao Zhang, Hongyu Jie, Yong Wu, Xinai Han, Xing Li, Yi He, Xingliang Shi, Yuwei Luo, Ying Sun, Jinlong Yang, Jing Yang, Shulv Quan, Xiaobin Lao, Liping Tan, Erwei Sun
Format: Article
Language:English
Published: BMC 2020-10-01
Series:Arthritis Research & Therapy
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13075-020-02332-7
_version_ 1828833863770570752
author Mingjiao Zhang
Hongyu Jie
Yong Wu
Xinai Han
Xing Li
Yi He
Xingliang Shi
Yuwei Luo
Ying Sun
Jinlong Yang
Jing Yang
Shulv Quan
Xiaobin Lao
Liping Tan
Erwei Sun
author_facet Mingjiao Zhang
Hongyu Jie
Yong Wu
Xinai Han
Xing Li
Yi He
Xingliang Shi
Yuwei Luo
Ying Sun
Jinlong Yang
Jing Yang
Shulv Quan
Xiaobin Lao
Liping Tan
Erwei Sun
author_sort Mingjiao Zhang
collection DOAJ
description Abstract Background Necroptosis is a form of regulated necrosis that is involved in various autoimmune diseases. Mixed lineage kinase domain-like pseudokinase (MLKL) has been identified as a key executor of necroptosis; however, the significance of MLKL in peripheral blood mononuclear cells (PBMCs) of systemic lupus erythematosus (SLE) has not been investigated. In this study, we aimed to determine the mRNA level of MLKL in PBMCs and examine its relationship with clinical features and serological parameters in SLE. Methods Real-time transcription-polymerase chain reaction (RT-PCR) analysis was used to determine the expression of MLKL mRNA in PBMCs from 59 patients with SLE, 25 patients with rheumatoid arthritis (RA), and 30 age- and sex-matched healthy controls (HC). Spearman’s correlation test was performed to assess the correlation of MLKL mRNA with clinical variables. The receiver operating characteristic (ROC) curve was created to evaluate the diagnostic value. Results Our results showed MLKL mRNA in PBMCs was upregulated in SLE patients compared to that in RA and HC individuals. SLE patients positive for antinuclear antibodies had significantly higher MLKL mRNA than antibody-negative patients. In SLE patients, MLKL mRNA was found to be upregulated in patients with lupus nephritis (LN) as compared with patients without LN, and also higher in active patients than in stable patients. MLKL mRNA level was significantly and positively correlated with c-reaction protein (CRP) (r = 0.3577, p = 0.0237), erythrocyte sedimentation rate (ESR) (r = 0.4091, p = 0.0043), serum immunoglobulin G (IgG) concentration (r = 0.3546, p = 0.0289), and the numbers of positive antinuclear antibodies (ANAs) (r = 0.3945, p = 0.0432). ROC analysis showed that MLKL mRNA in PBMCs had an area under the curve of 0.9277 (95% CI 0.8779–0.9775, p < 0.001) to discriminate SLE from controls. Conclusions These results suggest that increased MLKL mRNA level in the PBMCs of SLE patients is correlated with renal involvement and disease activity, identifying a subgroup of patients with SLE or LN who may benefit from early diagnosis and therapies targeting MLKL.
first_indexed 2024-12-12T17:28:32Z
format Article
id doaj.art-d5da6a9dff1a4aea9a10382811e15c2e
institution Directory Open Access Journal
issn 1478-6362
language English
last_indexed 2024-12-12T17:28:32Z
publishDate 2020-10-01
publisher BMC
record_format Article
series Arthritis Research & Therapy
spelling doaj.art-d5da6a9dff1a4aea9a10382811e15c2e2022-12-22T00:17:27ZengBMCArthritis Research & Therapy1478-63622020-10-012211810.1186/s13075-020-02332-7Increased MLKL mRNA level in the PBMCs is correlated with autoantibody production, renal involvement, and SLE disease activityMingjiao Zhang0Hongyu Jie1Yong Wu2Xinai Han3Xing Li4Yi He5Xingliang Shi6Yuwei Luo7Ying Sun8Jinlong Yang9Jing Yang10Shulv Quan11Xiaobin Lao12Liping Tan13Erwei Sun14Department of Rheumatology and Immunology, The Third Affiliated Hospital, Southern Medical UniversityDepartment of Rheumatology and Immunology, The Third Affiliated Hospital, Southern Medical UniversityClinical Medical Laboratory Center, The First Affiliated Hospital, Jinan UniversityDepartment of Rheumatology and Immunology, The Third Affiliated Hospital, Southern Medical UniversityDepartment of Rheumatology and Immunology, The Third Affiliated Hospital, Southern Medical UniversityDepartment of Rheumatology and Immunology, The Third Affiliated Hospital, Southern Medical UniversityDepartment of Rheumatology and Immunology, The Third Affiliated Hospital, Southern Medical UniversityDepartment of Rheumatology and Immunology, The Third Affiliated Hospital, Southern Medical UniversityDepartment of Rheumatology and Immunology, The Third Affiliated Hospital, Southern Medical UniversityDepartment of Rheumatology and Immunology, The Third Affiliated Hospital, Southern Medical UniversityDepartment of Rheumatology and Immunology, The Third Affiliated Hospital, Southern Medical UniversityDepartment of Rheumatology and Immunology, The Third Affiliated Hospital, Southern Medical UniversityDepartment of Rheumatology and Immunology, The Third Affiliated Hospital, Southern Medical UniversityDepartment of Rheumatology and Immunology, The Third Affiliated Hospital, Southern Medical UniversityDepartment of Rheumatology and Immunology, The Third Affiliated Hospital, Southern Medical UniversityAbstract Background Necroptosis is a form of regulated necrosis that is involved in various autoimmune diseases. Mixed lineage kinase domain-like pseudokinase (MLKL) has been identified as a key executor of necroptosis; however, the significance of MLKL in peripheral blood mononuclear cells (PBMCs) of systemic lupus erythematosus (SLE) has not been investigated. In this study, we aimed to determine the mRNA level of MLKL in PBMCs and examine its relationship with clinical features and serological parameters in SLE. Methods Real-time transcription-polymerase chain reaction (RT-PCR) analysis was used to determine the expression of MLKL mRNA in PBMCs from 59 patients with SLE, 25 patients with rheumatoid arthritis (RA), and 30 age- and sex-matched healthy controls (HC). Spearman’s correlation test was performed to assess the correlation of MLKL mRNA with clinical variables. The receiver operating characteristic (ROC) curve was created to evaluate the diagnostic value. Results Our results showed MLKL mRNA in PBMCs was upregulated in SLE patients compared to that in RA and HC individuals. SLE patients positive for antinuclear antibodies had significantly higher MLKL mRNA than antibody-negative patients. In SLE patients, MLKL mRNA was found to be upregulated in patients with lupus nephritis (LN) as compared with patients without LN, and also higher in active patients than in stable patients. MLKL mRNA level was significantly and positively correlated with c-reaction protein (CRP) (r = 0.3577, p = 0.0237), erythrocyte sedimentation rate (ESR) (r = 0.4091, p = 0.0043), serum immunoglobulin G (IgG) concentration (r = 0.3546, p = 0.0289), and the numbers of positive antinuclear antibodies (ANAs) (r = 0.3945, p = 0.0432). ROC analysis showed that MLKL mRNA in PBMCs had an area under the curve of 0.9277 (95% CI 0.8779–0.9775, p < 0.001) to discriminate SLE from controls. Conclusions These results suggest that increased MLKL mRNA level in the PBMCs of SLE patients is correlated with renal involvement and disease activity, identifying a subgroup of patients with SLE or LN who may benefit from early diagnosis and therapies targeting MLKL.http://link.springer.com/article/10.1186/s13075-020-02332-7SLENecroptosisMLKLmRNAPBMCsDiagnosis
spellingShingle Mingjiao Zhang
Hongyu Jie
Yong Wu
Xinai Han
Xing Li
Yi He
Xingliang Shi
Yuwei Luo
Ying Sun
Jinlong Yang
Jing Yang
Shulv Quan
Xiaobin Lao
Liping Tan
Erwei Sun
Increased MLKL mRNA level in the PBMCs is correlated with autoantibody production, renal involvement, and SLE disease activity
Arthritis Research & Therapy
SLE
Necroptosis
MLKL
mRNA
PBMCs
Diagnosis
title Increased MLKL mRNA level in the PBMCs is correlated with autoantibody production, renal involvement, and SLE disease activity
title_full Increased MLKL mRNA level in the PBMCs is correlated with autoantibody production, renal involvement, and SLE disease activity
title_fullStr Increased MLKL mRNA level in the PBMCs is correlated with autoantibody production, renal involvement, and SLE disease activity
title_full_unstemmed Increased MLKL mRNA level in the PBMCs is correlated with autoantibody production, renal involvement, and SLE disease activity
title_short Increased MLKL mRNA level in the PBMCs is correlated with autoantibody production, renal involvement, and SLE disease activity
title_sort increased mlkl mrna level in the pbmcs is correlated with autoantibody production renal involvement and sle disease activity
topic SLE
Necroptosis
MLKL
mRNA
PBMCs
Diagnosis
url http://link.springer.com/article/10.1186/s13075-020-02332-7
work_keys_str_mv AT mingjiaozhang increasedmlklmrnalevelinthepbmcsiscorrelatedwithautoantibodyproductionrenalinvolvementandslediseaseactivity
AT hongyujie increasedmlklmrnalevelinthepbmcsiscorrelatedwithautoantibodyproductionrenalinvolvementandslediseaseactivity
AT yongwu increasedmlklmrnalevelinthepbmcsiscorrelatedwithautoantibodyproductionrenalinvolvementandslediseaseactivity
AT xinaihan increasedmlklmrnalevelinthepbmcsiscorrelatedwithautoantibodyproductionrenalinvolvementandslediseaseactivity
AT xingli increasedmlklmrnalevelinthepbmcsiscorrelatedwithautoantibodyproductionrenalinvolvementandslediseaseactivity
AT yihe increasedmlklmrnalevelinthepbmcsiscorrelatedwithautoantibodyproductionrenalinvolvementandslediseaseactivity
AT xingliangshi increasedmlklmrnalevelinthepbmcsiscorrelatedwithautoantibodyproductionrenalinvolvementandslediseaseactivity
AT yuweiluo increasedmlklmrnalevelinthepbmcsiscorrelatedwithautoantibodyproductionrenalinvolvementandslediseaseactivity
AT yingsun increasedmlklmrnalevelinthepbmcsiscorrelatedwithautoantibodyproductionrenalinvolvementandslediseaseactivity
AT jinlongyang increasedmlklmrnalevelinthepbmcsiscorrelatedwithautoantibodyproductionrenalinvolvementandslediseaseactivity
AT jingyang increasedmlklmrnalevelinthepbmcsiscorrelatedwithautoantibodyproductionrenalinvolvementandslediseaseactivity
AT shulvquan increasedmlklmrnalevelinthepbmcsiscorrelatedwithautoantibodyproductionrenalinvolvementandslediseaseactivity
AT xiaobinlao increasedmlklmrnalevelinthepbmcsiscorrelatedwithautoantibodyproductionrenalinvolvementandslediseaseactivity
AT lipingtan increasedmlklmrnalevelinthepbmcsiscorrelatedwithautoantibodyproductionrenalinvolvementandslediseaseactivity
AT erweisun increasedmlklmrnalevelinthepbmcsiscorrelatedwithautoantibodyproductionrenalinvolvementandslediseaseactivity